<i>In Vitro</i> and <i>In Vivo</i> Antibacterial Activities of a Novel Quinolone Compound, OPS-2071, against Clostridioides difficile
Daisuke Oka(Otsuka (Japan)), Makoto Matsumoto(Tottori University Hospital), Katsuya Inagaki(Otsuka (Japan)), Hisashi Miyamoto(Otsuka (Japan)), Yuta Asakawa(Otsuka (Japan)), Fangguo Ye, Toshiyuki Shiragiku(Otsuka (Japan)), Abudusaimi Mamuti, Kinue Ohguro(Otsuka (Japan)), Xue Jingbo, Yukitaka Uematsu(Otsuka (Japan)), Jiangqin Sun, Liang Chen(University at Buffalo, State University of New York), Naomitsu Yamaya(Otsuka (Japan)), Takuya Kuno(Otsuka (Japan)), Jie‐Fei Cheng
Cited by 9
Related Papers
A Toll-like receptor recognizes bacterial DNA
|Nature|2000|6.4k
HTLV-I ASSOCIATED MYELOPATHY, A NEW CLINICAL ENTITY
|The Lancet|1986|2.4k
Targeted Disruption of the MyD88 Gene Results in Loss of IL-1- and IL-18-Mediated Function
|Immunity|1998|2k
Essential role of Stat6 in IL-4 signalling
|Nature|1996|1.6k
Targeted disruption of the mouse <i>Stat3</i> gene leads to early embryonic lethality
|Proceedings of the National Academy of Sciences|1997|1.3k